TY - JOUR
T1 - Mortality prediction in chronic obstructive pulmonary disease comparing GOLD2015 and GOLD2019 staging
T2 - a pooled analysis of individual patient data
AU - García Castillo, Elena
AU - Alonso Pérez, Tamara
AU - Ancochea, Julio
AU - Pastor-Sanz, Teresa María
AU - Almagro, Pere
AU - Martinez-Camblor, Pablo
AU - Rodriguez-Carballeira, Monica
AU - Navarro, Annie
AU - Lamprecht, Bernd
AU - Sofia Ramírez, Ana
AU - Kaiser, Bernhard
AU - Alfageme, Inmaculada
AU - Casanova, Ciro
AU - Esteban, Cristobal
AU - Soler Cataluña, Juan José
AU - Celli, Bartolome
AU - Marin, Jose Maria
AU - Ter Riet, Gerben
AU - Sobradillo, Patricia
AU - Lange, Peter
AU - Garcia-Aymerich, Judith
AU - Antó,, Josep Maria
AU - Turner, Alice
AU - Han, MeiLan
AU - Langhammer, Arnulf
AU - Vikjord, Sigrid Anna
AU - Sternberg, Alice
AU - Leivseth, Linda
AU - Bakke, Per
AU - Johannessen, Ane
AU - Oga, Toru
AU - Cosio, Borja
AU - IdISBa, CIBERES
AU - Echazarreta, Andrés
AU - Roche, Nicolas
AU - Burgel, Pierre-Régis
AU - Sin, Don
AU - Puhan, Milo
AU - Lopez-Campos, Jose Luis
AU - Carrasco, Laura
AU - Soriano, Joan B
PY - 2020/10/28
Y1 - 2020/10/28
N2 - In 2019, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposed a clinical grading system for patients with chronic obstructive pulmonary disease (COPD) with 4 categories (A-D) based on symptoms and exacerbation history.As part of the COPD Cohorts Collaborative International Assessment (3CIA) initiative, we aim to compare mortality prediction of 2015 and 2019 COPD GOLD staging systems.We studied 17 139 COPD patients from the 3CIA study, selecting those with complete data. Patients were classified by the 2015 and 2019 GOLD ABCD systems and we compared the predictive ability for 5-year mortality of both classifications.17 139 patients with COPD were enrolled in 22 cohorts of 11 countries; 8823 of them had complete data and were analyzed. Mean age was 63.9 years(SD 9.8); 5 552(62.9%) were male and mean FEV1 was 54.8%(SD 22.3). Compared with 2015, the GOLD 2019 classified the patients in milder degrees of COPD:groups C and D decreased from 13.6% to 5.8% and 40% to 17.8% respectively (p< 0.001). Five-year mortality did not differ between groups B and C in GOLD 2015; in contrast, in GOLD 2019, five-year mortality was greater for group B than C.When analyzing individually the prognostic accuracy of each of the groups, patients classified as group A and B had better sensitivity and positive predictive value with GOLD 2019 classification than GOLD 2015. On the contrary, GOLD 2015 had better sensitivity for group C and D than GOLD 2019. The AUC for 5-year mortality were only 0.67 (95% CI 0.66-0.68) for GOLD 2015 and 0.65 (95% CI 0.63-0.66) for GOLD 2019.GOLD 2019 does not predict mortality better than GOLD 2015 system.
AB - In 2019, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposed a clinical grading system for patients with chronic obstructive pulmonary disease (COPD) with 4 categories (A-D) based on symptoms and exacerbation history.As part of the COPD Cohorts Collaborative International Assessment (3CIA) initiative, we aim to compare mortality prediction of 2015 and 2019 COPD GOLD staging systems.We studied 17 139 COPD patients from the 3CIA study, selecting those with complete data. Patients were classified by the 2015 and 2019 GOLD ABCD systems and we compared the predictive ability for 5-year mortality of both classifications.17 139 patients with COPD were enrolled in 22 cohorts of 11 countries; 8823 of them had complete data and were analyzed. Mean age was 63.9 years(SD 9.8); 5 552(62.9%) were male and mean FEV1 was 54.8%(SD 22.3). Compared with 2015, the GOLD 2019 classified the patients in milder degrees of COPD:groups C and D decreased from 13.6% to 5.8% and 40% to 17.8% respectively (p< 0.001). Five-year mortality did not differ between groups B and C in GOLD 2015; in contrast, in GOLD 2019, five-year mortality was greater for group B than C.When analyzing individually the prognostic accuracy of each of the groups, patients classified as group A and B had better sensitivity and positive predictive value with GOLD 2019 classification than GOLD 2015. On the contrary, GOLD 2015 had better sensitivity for group C and D than GOLD 2019. The AUC for 5-year mortality were only 0.67 (95% CI 0.66-0.68) for GOLD 2015 and 0.65 (95% CI 0.63-0.66) for GOLD 2019.GOLD 2019 does not predict mortality better than GOLD 2015 system.
U2 - 10.1183/13993003.congress-2020.966
DO - 10.1183/13993003.congress-2020.966
M3 - Abstract
SN - 0903-1936
VL - 56
JO - The European respiratory journal
JF - The European respiratory journal
IS - Supp 64
M1 - 966
ER -